Search Result: gene

editing technologyLentivirus gene knockout technologyFLIPRTetraEnVison & PHERAStarTop countLiquid

and VEGFR would activate luciferase reporter gene expression.

It is a milestone on the path to industrialization of the cell and gene therapy industry, pioneered by

AAV vector is the most widely used vehicle in delivering gene of interest (GOI) in in vivo gene therapies.ProBio

synthesis to Top 6 clones14 weeks from gene synthesis to Top 1 clone Excellent DeliverablesAntibody

We will be able to meet the rapidly evolving demands of gene, cell, antibody and protein therapies.

trials, and has successfully delivered a number of CMC and GMP production projects.ProBio 's integrated gene

expedited timeline, good Ab sequence diversity and better cost-effectiveness.Case Study: TIGIT RGA Reporter Gene

The demand for viral vectors is rapidly increasing due to the recent growth of the gene therapy market

ProBio’s total cell and gene therapy solution covers CMC of plasmid and virus for IND filing as well